1. Notifying CDRH of a permanent discontinuance or interruption in manufacturing of a device under Section 506J of the FD&C Act during the COVID-19 public health emergency (revised): guidance for industry and Food and Drug Administration staff Publication: [Silver Spring, MD] : Center for Devices and Radiological Health, November 2020 Subject(s): Equipment and SuppliesManufacturing IndustryMedical Device LegislationCOVID-19United StatesUnited States. Department of Health and Human ServicesUnited States. Food and Drug Administration
